BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 29129316)

  • 1. Functional Consequences of CHRNA7 Copy-Number Alterations in Induced Pluripotent Stem Cells and Neural Progenitor Cells.
    Gillentine MA; Yin J; Bajic A; Zhang P; Cummock S; Kim JJ; Schaaf CP
    Am J Hum Genet; 2017 Dec; 101(6):874-887. PubMed ID: 29129316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered neuronal physiology, development, and function associated with a common chromosome 15 duplication involving CHRNA7.
    Meganathan K; Prakasam R; Baldridge D; Gontarz P; Zhang B; Urano F; Bonni A; Maloney SE; Turner TN; Huettner JE; Constantino JN; Kroll KL
    BMC Biol; 2021 Jul; 19(1):147. PubMed ID: 34320968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human clinical phenotypes of altered CHRNA7 copy number.
    Gillentine MA; Schaaf CP
    Biochem Pharmacol; 2015 Oct; 97(4):352-362. PubMed ID: 26095975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copy number variations in healthy subjects. Case study: iPSC line CSSi005-A (3544) production from an individual with variation in 15q13.3 chromosome duplicating gene CHRNA7.
    Turco EM; Vinci E; Altieri F; Ferrari D; Torres B; Goldoni M; Lamorte G; Tata AM; Mazzoccoli G; Postorivo D; Della Monica M; Bernardini L; Vescovi AL; Rosati J
    Stem Cell Res; 2018 Oct; 32():73-77. PubMed ID: 30218896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHRNA7 triplication associated with cognitive impairment and neuropsychiatric phenotypes in a three-generation pedigree.
    Soler-Alfonso C; Carvalho CM; Ge J; Roney EK; Bader PI; Kolodziejska KE; Miller RM; Lupski JR; Stankiewicz P; Cheung SW; Bi W; Schaaf CP
    Eur J Hum Genet; 2014 Sep; 22(9):1071-6. PubMed ID: 24424125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An acetylcholine alpha7 positive allosteric modulator rescues a schizophrenia-associated brain endophenotype in the 15q13.3 microdeletion, encompassing CHRNA7.
    Gass N; Weber-Fahr W; Sartorius A; Becker R; Didriksen M; Stensbøl TB; Bastlund JF; Meyer-Lindenberg A; Schwarz AJ
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1150-60. PubMed ID: 27061851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of single gene deletions at 15q13.3: further evidence that CHRNA7 causes the 15q13.3 microdeletion syndrome phenotype.
    Hoppman-Chaney N; Wain K; Seger PR; Superneau DW; Hodge JC
    Clin Genet; 2013 Apr; 83(4):345-51. PubMed ID: 22775350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cognitive and Behavioral Phenotypes of Individuals with CHRNA7 Duplications.
    Gillentine MA; Berry LN; Goin-Kochel RP; Ali MA; Ge J; Guffey D; Rosenfeld JA; Hannig V; Bader P; Proud M; Shinawi M; Graham BH; Lin A; Lalani SR; Reynolds J; Chen M; Grebe T; Minard CG; Stankiewicz P; Beaudet AL; Schaaf CP
    J Autism Dev Disord; 2017 Mar; 47(3):549-562. PubMed ID: 27853923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mosaic 15q13.3 deletion including CHRNA7 gene in monozygotic twins.
    Popovici C; Busa T; Missirian C; Milh M; Moncla A; Philip N
    Eur J Med Genet; 2013 May; 56(5):274-7. PubMed ID: 23454271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 15q13.3 duplication in two patients with childhood-onset schizophrenia.
    Zhou D; Gochman P; Broadnax DD; Rapoport JL; Ahn K
    Am J Med Genet B Neuropsychiatr Genet; 2016 Sep; 171(6):777-83. PubMed ID: 26968334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duplication Versus Deletion Through the Lens of 15q13.3: Clinical and Research Implications of Studying Copy Number Variants Associated with Neuropsychiatric Disorders in Induced Pluripotent Stem Cell-Derived Neurons.
    Antony I; Narasimhan M; Shen R; Prakasam R; Kaushik K; Chapman G; Kroll KL
    Stem Cell Rev Rep; 2023 Apr; 19(3):639-650. PubMed ID: 36370261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A de novo nonsense mutation in ZBTB18 plus a de novo 15q13.3 microdeletion in a 6-year-old female.
    Ehmke N; Karge S; Buchmann J; Korinth D; Horn D; Reis O; Häßler F
    Am J Med Genet A; 2017 May; 173(5):1251-1256. PubMed ID: 28345786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A small homozygous microdeletion of 15q13.3 including the CHRNA7 gene in a girl with a spectrum of severe neurodevelopmental features.
    Liao J; DeWard SJ; Madan-Khetarpal S; Surti U; Hu J
    Am J Med Genet A; 2011 Nov; 155A(11):2795-800. PubMed ID: 21990074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Phenotypic Spectrum of 15q13.3 Region Duplications: Report of 5 Patients.
    Budisteanu M; Papuc SM; Streata I; Cucu M; Pirvu A; Serban-Sosoi S; Erbescu A; Andrei E; Iliescu C; Ioana D; Severin E; Ioana M; Arghir A
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome 15q13.3 microduplications are associated with treatment refractory major depressive disorder.
    McClain L; Segreti AM; Nau S; Shaw P; Finegold DN; Pan LA; Peters DG
    Genes Brain Behav; 2020 Jun; 19(5):e12628. PubMed ID: 31828948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide gene expression in a patient with 15q13.3 homozygous microdeletion syndrome.
    Le Pichon JB; Yu S; Kibiryeva N; Graf WD; Bittel DC
    Eur J Hum Genet; 2013 Oct; 21(10):1093-9. PubMed ID: 23361223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 15q13.3 deletion syndrome: Deficient α(7)-containing nicotinic acetylcholine receptor-mediated neurotransmission in the pathogenesis of neurodevelopmental disorders.
    Deutsch SI; Burket JA; Benson AD; Urbano MR
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():109-17. PubMed ID: 26257138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted therapy with galantamine in a pediatric patient with 15q13.3 deletion syndrome.
    Casas-Alba D; Nolasco GA; Díez-Juan M; Mezzatesta M; Balañá G; Fons C
    Am J Med Genet A; 2021 Dec; 185(12):3897-3899. PubMed ID: 34272916
    [No Abstract]   [Full Text] [Related]  

  • 19. CHRNA7 Deletions are Enriched in Risperidone-Treated Children and Adolescents.
    Gillentine MA; White JJ; Grochowski CM; Lupski JR; Schaaf CP; Calarge CA
    J Child Adolesc Psychopharmacol; 2017 Dec; 27(10):908-915. PubMed ID: 28817303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further delineation of eye manifestations in homozygous 15q13.3 microdeletions including TRPM1: a differential diagnosis of ceroid lipofuscinosis.
    Masurel-Paulet A; Drumare I; Holder M; Cuisset JM; Vallée L; Defoort S; Bourgois B; Pernes P; Cuvellier JC; Huet F; Chehadeh SE; Thevenon J; Callier P; Thauvin C; Faivre L; Andrieux J
    Am J Med Genet A; 2014 Jun; 164A(6):1537-44. PubMed ID: 24668847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.